Clinical Trial Update: Concomitant Treatment of Permanent Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on concomitant treatment of permanent atrial fibrillation conducted by AtriCure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: AtriCure, Inc. | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED